Article
Radiological and pathological integration predicts the efficacy of bevacizumab with chemotherapy in colorectal cancer liver metastases
2025-11-18
Abstract excerpt
<title>Abstract</title> <p>While bevacizumab plus chemotherapy is considered the standard therapy for unresectable colorectal cancer liver metastases, a substantial proportion of patients exhibit inadequate responses. This underscores the pressing need for reliable predictive biomarkers. Recent advances in radiomics and pathomics offer robust frameworks for developing sufficiently accurate signatures. However, th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 94f83d4a-26b8-50a7-b8ed-0e04fc65f3ef
- DOI
- 10.21203/rs.3.rs-7808212/v1
